UK SBS Seahorse XFe96 Analyser
Estimated value
£149k
Awarded value
£149k
Suppliers
1
Lots
1
Published
08 May 2017
Description
There is no other instrument on the market or in development that can analyse cellular metabolism at this high level. We were one of the pioneer research groups to adopt this technology and published several papers in high impact journals, which could not have been produced without the Seahorse Technology. The Seahorse XFE is now an essential tool in cancer metabolism studies and mitochondrial toxicity research worldwide. Both these areas are priority research projects within the MRC Toxicology Unit strategic plan.
Scope
- Reference
- RE17171
- Total value
- £148,907.2 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 03 May 2017 to 02 Jun 2022
- CPV classifications
- 38434000
Submission & procedure
- Submission deadline
- 02 May 2017, 11:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£149k
Award date
02 May 2017
Contract start
03 May 2017
Contract end
02 Jun 2022